Education
About Us
Working with TipRanks
Follow Us
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
BridgeBio Pharma (BBIO) Ownership Overview
29.25% Insiders
16.80% Mutual Funds
0.62% Other Institutional Investors
14.11% ETFs
39.22% Public Companies and Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 31.53% of the company’s stock is owned by Institutional Investors, 29.25% is owned by Insiders, and 39.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 14, 2025 | xxxxxxxxxxxxx | $205200000 | |
May 06, 2025 | xxxxxxxxxxxxx | $39501 | |
May 06, 2025 | xxxxxxxxxxxxx | $3849000 | |
Mar 07, 2025 | xxxxxxxxxxxxx | $197760000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $518550 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $815229 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2431999 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $4225940 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 22,055,375 | Institution | 11.62% | 744,148,353 | |
| 22,055,375 | Insider | 11.62% | 744,148,353 | |
| 14,394,700 | Institution | 7.58% | 485,677,178 | |
| 13,260,971 | Insider | 6.98% | 447,425,162 | |
| 13,083,214 | Institution | 6.89% | 441,427,640 | |
| 9,959,504 | Insider | 5.59% | 336,033,665 | |
| 7,240,479 | Institution | 3.81% | 244,293,761 | |
| 6,068,125 | Institution | 3.20% | 204,738,538 | |
| 5,731,000 | Institution | 3.02% | 193,363,940 | |
| 2,754,679 | Institution | 1.45% | 92,942,869 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,083,214 | Institution | 6.89% | 441,427,640 | |
| 2,460,481 | Institution | 1.30% | 83,016,629 | |
| 1,868,196 | Institution | 0.98% | 63,032,933 | |
| 1,560,821 | Institution | 0.82% | 52,662,101 | |
| 1,515,052 | Institution | 0.80% | 51,117,854 | |
| 1,488,938 | Institution | 0.78% | 50,236,768 | |
| 915,553 | Institution | 0.48% | 30,890,758 | |
| 802,019 | Institution | 0.42% | 27,060,121 | |
| 799,119 | Institution | 0.42% | 26,962,275 | |
| 771,787 | Institution | 0.41% | 26,040,093 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,869,226 | Institution | 2.56% | 186,783,509 | |
| 3,849,900 | Institution | 2.03% | 105,641,256 | |
| 3,590,745 | Institution | 1.89% | 121,151,736 | |
| 2,453,589 | Institution | 1.29% | 82,587,806 | |
| 2,278,145 | Institution | 1.20% | 87,389,642 | |
| 2,126,501 | Institution | 1.12% | 81,572,578 | |
| 928,605 | Institution | 0.49% | 31,331,133 | |
| 772,646 | Institution | 0.41% | 26,069,076 | |
| 702,003 | Institution | 0.37% | 26,928,835 | |
| 701,514 | Institution | 0.37% | 23,612,961 |
FAQ
Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 0.62% of the company's stock is held by institutional investors, 29.25% is held by insiders, and 39.22% is held by retail investors.
What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.62% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.22% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
Andreas Halvorsen owns the most shares of BridgeBio Pharma Inc (BBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.